Caffeine powder is recalled

May 21, 2007

The U.S. Food and Drug Administration said Spectrum Laboratory Products Inc. is recalling its Caffeine Citrated Powder due to potential potency issues.

The Gardena, Calif., company distributes its purified caffeine powder -- a cerebral and respiratory stimulant -- nationwide, primarily to treat idiopathic apnea experienced by premature infants.

The company initiated the recall after blood levels of caffeine in patients were determined to be significantly lower than would be expected. The FDA said use of sub-potent compounded preparations could result in sub-therapeutic caffeine blood levels and an unacceptable risk of respiratory depression.

Recalled lots of the Caffeine Citrated Powder, Purified, include code numbers TS0225, UK0821 and VI1203.

The recalled product was distributed to pharmacies, hospitals, two universities, laboratories and pharmacy distributors. It can be identified by catalog number CA110 and the name "Caffeine Citrated, Powder, Purified" on the label.

Consumers with questions can contact company representative Stephen Newton at 800-791-3210, Ext. 349.

Copyright 2007 by United Press International

Explore further: Medical device surveillance on the horizon

add to favorites email to friend print save as pdf

Related Stories

Google hits back at rivals with futuristic HQ plan

11 hours ago

Google unveiled plans Friday for a new campus headquarters integrating wildlife and sweeping waterways, aiming to make a big statement in Silicon Valley—which is already seeing ambitious projects from Apple ...

Recommended for you

Medical device surveillance on the horizon

just added

Thousands of people around the world have been exposed to toxic chemicals generated by their metal hip implants. Similarly, many patients have contracted infections from pieces of implanted mesh used in hernia-repair surgery, ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.